title: Choosing Treatments on the Basis of Cost: Can Clinicians Opt for Less Expensive Treatments?
authors.affiliation: Center for Drug Policy, Partners Healthcare, Needham; Massachusetts General Hospital; and Harvard Medical School, Boston, MA preddy2@partners.org.
authors.forename: Prabashni
authors.initials: P
authors.lastname: Reddy
authors.affiliation: Center for Drug Policy, Partners Healthcare, Needham; Massachusetts General Hospital; and Harvard Medical School, Boston, MA.
authors.forename: Gayle C
authors.initials: GC
authors.lastname: Blouin
authors.affiliation: Center for Drug Policy, Partners Healthcare, Needham; Massachusetts General Hospital; and Harvard Medical School, Boston, MA.
authors.forename: Yu-Chen
authors.initials: YC
authors.lastname: Yeh
authors.affiliation: Center for Drug Policy, Partners Healthcare, Needham; Massachusetts General Hospital; and Harvard Medical School, Boston, MA.
authors.forename: Harold J
authors.initials: HJ
authors.lastname: Burstein
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics*; D003363:Cost Control; D016527:Drug Costs; D006801:Humans
chemical_list: D000970:Antineoplastic Agents